Project Details
Projekt
GSC 108: Hannover Biomedical Research School (HBRS)
Subject Area
Medicine
Term
from 2006 to 2014
Project identifier
Deutsche Forschungsgemeinschaft (DFG) - Project number 24390159
In the year 2000, Hannover Medical School (MHH), one of Germany's leading medical schools, was the first to establish a structured and accredited interdisciplinary PhD programme. Just three years later, MHH founded the Hannover Biomedical Research School (HBRS) as an "umbrella organisation" for existing and future structured postgraduate programmes. HBRS now comprises two international PhD programmes (Molecular Medicine and Infection Biology) and four DFG-funded Research Training Groups, two of which are joint European programmes. A third PhD programme in Regenerative Sciences will start in October 2007. Moreover, a structured doctoral programme for medical students has also been successfully established.
Already within this short period of time HBRS has managed to become a highly attractive graduate school for (MD)/PhD training with an outstanding international reputation. It coordinates teaching and ensures excellent training in high quality research laboratories, furthers motivation, and actively encourages integration and interdisciplinary exchange between students and young researchers from both medical and life science backgrounds. HBRS also fosters educational and scientific interaction between university and non-university institutions; among these are the University of Veterinary Medicine, the Helmholtz Institute for Infection Research (HZI) in Braunschweig, and the Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM) in Hannover.
It provides a framework for international guest lectures, summer schools and for the training of talented medical and life science students for a future career in science. In providing optimal conditions for female PhD students, HBRS aims to motivate, support and convince female academics to pursue a career in science. HBRS intends to become a "family-oriented" training facility. HBRS is also supporting a new model for clinical research scientists with the introduction of a dual career concept, involving rotation of positions and tandem research groups. Under the Excellence Initiative the financial basis for HBRS would be secure, allowing MHH to improve its postgraduate education still further. New curricular PhD programmes could be evolved, attracting excellent students and junior researchers from all over the world.
Already within this short period of time HBRS has managed to become a highly attractive graduate school for (MD)/PhD training with an outstanding international reputation. It coordinates teaching and ensures excellent training in high quality research laboratories, furthers motivation, and actively encourages integration and interdisciplinary exchange between students and young researchers from both medical and life science backgrounds. HBRS also fosters educational and scientific interaction between university and non-university institutions; among these are the University of Veterinary Medicine, the Helmholtz Institute for Infection Research (HZI) in Braunschweig, and the Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM) in Hannover.
It provides a framework for international guest lectures, summer schools and for the training of talented medical and life science students for a future career in science. In providing optimal conditions for female PhD students, HBRS aims to motivate, support and convince female academics to pursue a career in science. HBRS intends to become a "family-oriented" training facility. HBRS is also supporting a new model for clinical research scientists with the introduction of a dual career concept, involving rotation of positions and tandem research groups. Under the Excellence Initiative the financial basis for HBRS would be secure, allowing MHH to improve its postgraduate education still further. New curricular PhD programmes could be evolved, attracting excellent students and junior researchers from all over the world.
DFG Programme
Graduate Schools
Applicant Institution
Medizinische Hochschule Hannover
Participating Institution
Fraunhofer-Institut für Toxikologie und Experimentelle Medizin (ITEM); Helmholtz-Zentrum für Infektionsforschung (HZI); Friedrich-Loeffler-Institut
Bundesforschungsinstitut für Tiergesundheit
Institut für Nutztiergenetik; TWINCORE
Zentrum für Experimentelle und Klinische Infektionsforschung GmbH
Bundesforschungsinstitut für Tiergesundheit
Institut für Nutztiergenetik; TWINCORE
Zentrum für Experimentelle und Klinische Infektionsforschung GmbH
Participating University
Gottfried Wilhelm Leibniz Universität Hannover; Stiftung Tierärztliche Hochschule Hannover
Spokesperson
Professor Dr. Reinhold Ernst Schmidt (†)
Participating Researchers
Professor Dr. Christopher Baum; Professor Dr. Georg Behrens; Professor Dr. Armin Braun; Professor Dr. Reinhold Förster; Professor Dr. Matthias Gaestel; Professorin Dr. Rita Gerardy-Schahn; Professorin Dr.-Ing. Birgit Glasmacher; Professor Dr. Achim Gossler; Professorin Dr. Gesine Hansen; Dr. Hansjörg Hauser; Professor Dr. Dirk Heinz; Professor Dr. Georg Herrler; Professor Dr. Ulrich Kalinke; Professor Dr. Michael Peter Manns; Professor Dr. Dietmar J. Manstein; Professor Dr. Ulrich Martin; Professor Dr. Heiner Niemann; Professor Dr. Oliver Pabst; Professorin Dr. Brigitte Schlegelberger; Professor Dr. Thomas Schulz; Professorin Dr. Beate Sodeik; Professor Dr. Sebastian Suerbaum; Professor Dr. Thomas Thum, Ph.D.; Professor Dr. Thomas Werfel
